Abstract
Introduction The interest on early Spondyloarthtiris (eSpA) is born in the last ten years for the acknowledgment of the “evidence based” utility of the rapid diagnostic and therapeutic approach in this disease. The aim of this review was to discuss early spondyloarthritis in detail. Discussion The chronological definition of eSpA is not uniform in literature. ASAS criteria, together with the use of MRI and US in early diagnosis have increased the diagnostic power and the capacity to classify eSpA. Few issues investigated and codified the use of DMARDs and antiTNFalpha in early phases. Conclusion Future studies must be conducted in the future to better clarify MRI and US findings and the role of other imaging techniques in early phase. Furthermore, an intensified research on efficacy of treatments in early phase with prospective studies are needed in the future.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
